All News #Library
Rare Diseases
Affinia Pharma Granted EMA Orphan Drug Status For AFTX-201
18 Feb 2026 //
BUSINESSWIRE
Affinia Therapeutics and DCM Foundation Partner to Raise Awarenes
03 Jun 2025 //
BUSINESSWIRE

Market Place
Sourcing Support